Table 4 Outcomes in reverse and standard HCR
From: Clinical results after hybrid coronary revascularization with totally endoscopic coronary surgery
Reverse HCR (N = 44) | Standard HCR (N = 59) | p value | |
|---|---|---|---|
General | |||
Days between procedures | 46.23 ± 39.48 | 59.07 ± 57.42 | < 0.001 |
30-day mortality | 0 | 0 | |
All-cause mortality | 0 | 3 (1.75) | 0.129 |
30-day MACCE | 1 (2.27) | 1 (1.70) | 0.834 |
Cardiac death | 0 | 0 | |
Myocardial infarction | 0 | 0 | |
Stroke | 1 (2.27) | 0 | |
Revascularization | 0 | 1 (1.70) | |
Long-term MACCE | 3 (6.82) | 7 (11.86) | 0.392 |
Cardiac death | 0 | 0 | |
Myocardial infarction | 1 (2.27) | 1 (1.70) | |
Stroke | 1 (2.27) | 0 | |
Revascularization | 1 (2.27) | 6 (10.17) | |
Endo-CABG | |||
ICU LOS (h) | 72.70 ± 44.84 | 69.1 ± 47.35 | 0.697 |
Ventilation time (h) | 8.09 ± 7.93 | 11.75 ± 29.56 | 0.442 |
Hospital LOS (days) | 8.19 ± 4.03 | 7.27 ± 3.51 | 0.286 |
Cross-clamping time (min) | 50.10 ± 26.03 | 50.88 ± 25.54 | 0.885 |
CPB time (min) | 83.26 ± 37.29 | 99.71± 38.72 | 0.034 |
Perioperative bleeding (ml) | 506.30 ± 550.08 | 399.70 ± 340.76 | 0.266 |
Bleeding 24h (ml) | 560.30 ± 604.72 | 527.00 ± 805.99 | 0.812 |
LVEF | |||
> 50% | 16 (36.36) | 38 | 64.41) |
31–50% | 12 (27.27) | 7 | (11.86) |
21–30% | 0 | 1 (1.69) | |
< 20% | 0 | 0 | |
No TTE | 16 (36.36) | 13 (22.03) | |
New-onset AF | 10 (22.72) | 14 (23.73) | 0.956 |
Electric cardioversion | 10 (22.72) | 12 (20.34) | 0.770 |
In hospital neurological complications | 0.352 | ||
CVA | 1 (2.27) | 0 | |
TIA | 0 | 0 | |
Early revision | 4 (9.09) | 2 (3.39) | 0.222 |
Late revision | 1 (2.27) | 1 (1.70) | 0.834 |
Graft failure | 0 | 6 (10.17) | 0.029 |
PCI | |||
Number of stents | 1.51 ± 0.83 | 1.36 ± 0.69 | 0.318 |
In-stent stenosis | 2 (4.55) | 1 (1.70) | 0.678 |
Hospital LOS | 2.53 ± 2.95 | 1.58 ± 1.59 | 0.069 |